NEU neuren pharmaceuticals limited

Ann: Appendix 4C - quarterly, page-6

  1. 6,542 Posts.
    lightbulb Created with Sketch. 1855
    Good question HT. S'pose it's something we have to ponder. After all we are just shareholders and management owes us only what they think we should know. OK, there has been a deferment in expected expenditure, but the reason(s) are their business and not ours.

    [If expenditure goes @ 4m per quarter into the future with 16-17m on hand, won't be long before more $ are required unless an upfront materialises. Not a good look for a little Aussie battler with 5 orphan indications. Perhaps in this cat eats dog world circling sharks can toy with their prey - figures.]
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$12.96
Change
-0.140(1.07%)
Mkt cap ! $1.612B
Open High Low Value Volume
$13.20 $13.36 $12.82 $4.627M 354.8K

Buyers (Bids)

No. Vol. Price($)
1 7585 $12.96
 

Sellers (Offers)

Price($) Vol. No.
$13.03 3344 2
View Market Depth
Last trade - 16.10pm 16/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.